These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16379614)

  • 1. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL; Colice GL
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
    Donnell D
    Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans.
    Leach C
    J Allergy Clin Immunol; 1999 Dec; 104(6):S250-2. PubMed ID: 10588985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
    Leach CL; Kuehl PJ; Chand R; McDonald JD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inhaled steroids.
    Leach C
    Int J Clin Pract Suppl; 1998 Sep; 96():23-7. PubMed ID: 10344030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler.
    Soria I; Harrison LI; Machacek JH; Cline AC; Stampone PA
    Biopharm Drug Dispos; 1998 Jul; 19(5):297-302. PubMed ID: 9673781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL; Davidson PJ; Boudreau RJ
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.
    De Backer W; Devolder A; Poli G; Acerbi D; Monno R; Herpich C; Sommerer K; Meyer T; Mariotti F
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):137-48. PubMed ID: 20109122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children.
    Agertoft L; Laulund LW; Harrison LI; Pedersen S
    Pediatr Pulmonol; 2003 Mar; 35(3):192-9. PubMed ID: 12567387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
    Janssens HM; De Jongste JC; Hop WC; Tiddens HA
    Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.
    Kobayashi Y; Yasuba H; Asako M; Yamamoto T; Takano H; Tomoda K; Kanda A; Iwai H
    Front Immunol; 2018; 9():2192. PubMed ID: 30337921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.